Paclitaxel impairs endothelial cell adhesion but not cytokine-induced cellular adhesion molecule expression

Area of Science:

• Vascular biology
• Drug-eluting stent technology
• Endothelial cell function

Background:

• Drug-eluting stents deliver antiproliferative agents to prevent in-stent restenosis.
• Paclitaxel, a microtubule-stabilizing drug, is used on stents, but its effects on endothelial cells (ECs) are not well understood.
• Restoring EC function is crucial for vascular lesion repair.

Purpose of the Study:

• To assess the impact of paclitaxel on critical EC functions relevant to vascular injury.
• Specifically examining EC adhesion to matrix proteins, EC migration, and cytokine-stimulated cellular adhesion molecule (CAM) expression.

Main Methods:

• In vitro assessment of endothelial cell adhesion to matrix proteins.
• Evaluation of endothelial cell migration capacity.
• Analysis of tumor necrosis factor-stimulated CAM expression on EC surfaces following paclitaxel treatment.

Main Results:

• Paclitaxel significantly inhibited both EC adhesion to matrix proteins and EC migration.
• Paclitaxel did not affect tumor necrosis factor-stimulated CAM expression on ECs.
• Mechanisms involving protein kinase C and myosin light chain kinase were not implicated; MAP kinase ERK1/2 showed modest inhibition by paclitaxel.

Conclusions:

• While paclitaxel-coated stents may inhibit smooth muscle proliferation, their negative effects on EC adhesion and migration could limit therapeutic efficacy.
• The inability of paclitaxel to reduce cytokine-induced CAM expression on ECs further complicates its use.
• Further research is needed to optimize paclitaxel-eluting stents for comprehensive vascular repair.